Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor.
Nakano Y, Takadera M, Miyazaki M, Qiao Z, Nakajima K, Noguchi R, Oyama R, Kimura Y, Okuhiro Y, Yamasaki K, Kunihiro N, Fukushima H, Inoue T, Hara J, Ozawa T, Kondo T, Ichimura K.
Nakano Y, et al. Among authors: noguchi r.
Hum Cell. 2021 Jan;34(1):271-278. doi: 10.1007/s13577-020-00438-3. Epub 2020 Sep 30.
Hum Cell. 2021.
PMID: 32997328